Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × Pyruvic Acid × Clear all

Phase

Phase 2 2 Phase EARLY_PHASE1 1 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cyclophosphamide 367 Radiotherapy 241 fludarabine 206 Gemcitabine 183 Cisplatin 179 pembrolizumab 163 Nivolumab 162 Paclitaxel 155 Carboplatin 142 Magnetic Resonance Spectroscopy 140 fludarabine phosphate 137 Irinotecan 113 Bevacizumab 113 Cytarabine 112 Temozolomide 111 Capecitabine 105 Specimen Handling 104 Radiosurgery 104 Radiation 101 Docetaxel 100 Dexamethasone 96 Biopsy 96 Etoposide 94 Ipilimumab 93 Rituximab 92 Fluorouracil 91 Oxaliplatin 89 Filgrastim 87 Sorafenib 86 Lenalidomide 86

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02911467 2020-07-24

MR

University of California, San Francisco

Phase 1 Terminated

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡